SC 13G

Company

Chemomab Therapeutics Ltd.

Filed

August 20, 2024

Accession Number

0001178913-24-002709

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →